Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
about
Inflammation and nutrition in children with chronic kidney diseaseNonmuscle Tissues Contribution to Cancer CachexiaSkeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney DiseaseMechanisms of muscle wasting in chronic kidney diseaseProtein energy wasting in children with chronic kidney disease.Uninephrectomy in rats on a fixed food intake results in adipose tissue lipolysis implicating spleen cytokinesDexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats.Uninephrectomy in Rats on a Fixed Food Intake Potentiates Both Anorexia and Circulating Cytokine Subsets in Response to LPS.Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis.Uninephrectomy-Induced Lipolysis and Low-Grade Inflammation Are Mimicked by Unilateral Renal DenervationImpaired regeneration: A role for the muscle microenvironment in cancer cachexia.A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.Hypothalamic activation is essential for endotoxemia-induced acute muscle wasting.Role of the brain melanocortins in blood pressure regulation.Lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα) blunt the response of Neuropeptide Y/Agouti-related peptide (NPY/AgRP) glucose inhibited (GI) neurons to decreased glucose.Insulin ameliorating endotoxaemia-induced muscle wasting is associated with the alteration of hypothalamic neuropeptides and inflammation in rats.An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure.
P2860
Q26751530-A275FE3E-7A29-40B5-85BF-2FD62C3E365BQ26777562-ECDFDA98-0080-421E-9399-C781E4C9956EQ27334345-D6AA8A3B-E482-4E04-8CA0-B2AB1259C42FQ34723810-461693AA-C9F0-42C0-BEF3-ABC624A445ADQ35553088-CB1CB6D5-6FFA-4EA5-9031-732B1FC126D5Q35837305-71A6A167-CDBC-4DBA-82AA-FC89B1D291D3Q36328267-086CC08F-D4F8-469F-84DE-EAECC9BF1DF0Q36391967-FA8E94FA-1C09-4651-B05B-BAD19EAE0CDBQ36895482-49DB6332-B3BE-4566-8C43-F0523577D8A9Q37000940-B55C663B-122C-4814-BDF7-C049A2F7EB53Q37042189-4337BFAB-195B-4C10-A2F6-9FC472852BE0Q37411666-DEB239C3-6EDB-42ED-ADD2-6120F08C334DQ37475891-7AF2D5BF-E18F-4255-A6EA-6AB448298ADBQ39169242-ED39FE6B-C75E-435A-9DD6-388AC3F999C5Q39544008-8BC6C0A2-980B-4FFB-B129-4F973443A1A6Q41745913-C97EA24F-6943-4348-A39C-8D7E1B01F3BDQ46032685-9E299C8F-9888-43BD-A147-728040B69418
P2860
Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@ast
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@en
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@nl
type
label
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@ast
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@en
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@nl
prefLabel
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@ast
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@en
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@nl
P2860
P1476
Melanocortin antagonism amelio ...... ion in chronic kidney disease.
@en
P2093
Robert H Mak
Wai W Cheung
P2860
P304
P356
10.1152/AJPRENAL.00341.2012
P577
2012-08-22T00:00:00Z